BioCentury
ARTICLE | Product Development

$1B AMR Action Fund to assess first investments in 1Q21

Plus: PASTEUR Act seeking $11B over 10 years to fund antibiotic subscription model 

October 13, 2020 10:20 PM UTC

The $1 billion AMR Action Fund remains on track to begin assessing investment opportunities in 1Q21 aimed at addressing antimicrobial resistance.

In July, 23 pharmas banded together to create the fund to bridge the gap between Phase II testing and approval for biotechs trying to advance products that combat antimicrobial resistance against WHO or CDC-prioritized pathogens. ...